Codiom, Fatima S.

HRN: 09-21-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2022
CEFUROXIME 750MG (VIAL)
06/18/2022
06/24/2022
IV
750mg
Q8
Non Institutional Delivery; 2nd Degree Laceration

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: Non-compliant To Guidelines